 | • レポートコード：MRC2312MG15224 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の長時間作用型可逆的避妊薬（LARC）市場規模と予測を収録しています。・世界の長時間作用型可逆的避妊薬（LARC）市場：売上、2018年-2023年、2024年-2029年 ・世界の長時間作用型可逆的避妊薬（LARC）市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の長時間作用型可逆的避妊薬（LARC）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「子宮内避妊器具（IUC）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 長時間作用型可逆的避妊薬（LARC）のグローバル主要企業は、Bayer、 Merck、 Teva Pharmaceutical、 Allergan、 HRA Pharma、 Eurogine、 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.、 Wuxi Tianyi Medical Equipment Co., Ltd.、 SMB Corporation、 Shenyang Liren、 Tianjin Hejie Medical Equipment Co., Ltd.、 Cooper Companies、 AbbVie Allergan、 Organon、 Shanghai Dahua Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、長時間作用型可逆的避妊薬（LARC）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の長時間作用型可逆的避妊薬（LARC）市場：タイプ別、2018年-2023年、2024年-2029年 世界の長時間作用型可逆的避妊薬（LARC）市場：タイプ別市場シェア、2022年 ・子宮内避妊器具（IUC）、皮下インプラント 世界の長時間作用型可逆的避妊薬（LARC）市場：用途別、2018年-2023年、2024年-2029年 世界の長時間作用型可逆的避妊薬（LARC）市場：用途別市場シェア、2022年 ・20-24歳、25-34歳、35-44歳、その他 世界の長時間作用型可逆的避妊薬（LARC）市場：地域・国別、2018年-2023年、2024年-2029年 世界の長時間作用型可逆的避妊薬（LARC）市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における長時間作用型可逆的避妊薬（LARC）のグローバル売上、2018年-2023年 ・主要企業における長時間作用型可逆的避妊薬（LARC）のグローバル売上シェア、2022年 ・主要企業における長時間作用型可逆的避妊薬（LARC）のグローバル販売量、2018年-2023年 ・主要企業における長時間作用型可逆的避妊薬（LARC）のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Bayer、 Merck、 Teva Pharmaceutical、 Allergan、 HRA Pharma、 Eurogine、 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.、 Wuxi Tianyi Medical Equipment Co., Ltd.、 SMB Corporation、 Shenyang Liren、 Tianjin Hejie Medical Equipment Co., Ltd.、 Cooper Companies、 AbbVie Allergan、 Organon、 Shanghai Dahua Pharmaceutical ************************************************************* ・調査・分析レポートの概要 長時間作用型可逆的避妊薬（LARC）市場の定義 市場セグメント 世界の長時間作用型可逆的避妊薬（LARC）市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の長時間作用型可逆的避妊薬（LARC）市場規模 世界の長時間作用型可逆的避妊薬（LARC）市場規模：2022年 VS 2029年 世界の長時間作用型可逆的避妊薬（LARC）市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの長時間作用型可逆的避妊薬（LARC）の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の長時間作用型可逆的避妊薬（LARC）製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：子宮内避妊器具（IUC）、皮下インプラント 長時間作用型可逆的避妊薬（LARC）のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：20-24歳、25-34歳、35-44歳、その他 長時間作用型可逆的避妊薬（LARC）の用途別グローバル売上・予測 ・地域別市場分析 地域別長時間作用型可逆的避妊薬（LARC）市場規模 2022年と2029年 地域別長時間作用型可逆的避妊薬（LARC）売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Bayer、 Merck、 Teva Pharmaceutical、 Allergan、 HRA Pharma、 Eurogine、 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.、 Wuxi Tianyi Medical Equipment Co., Ltd.、 SMB Corporation、 Shenyang Liren、 Tianjin Hejie Medical Equipment Co., Ltd.、 Cooper Companies、 AbbVie Allergan、 Organon、 Shanghai Dahua Pharmaceutical ... |
This research report provides a comprehensive analysis of the Long-Acting Reversible Contraception(LARC) market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Long-Acting Reversible Contraception(LARC) market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Long-Acting Reversible Contraception(LARC), challenges faced by the industry, and potential opportunities for market players.
The global Long-Acting Reversible Contraception(LARC) market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Long-Acting Reversible Contraception(LARC) market presents opportunities for various stakeholders, including Age 20~24 Years Old, Age 25-34 Years Old. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Long-Acting Reversible Contraception(LARC) market. Additionally, the growing consumer demand present avenues for market expansion.
The global Long-Acting Reversible Contraception(LARC) market was valued at US$ 1088.4 million in 2022 and is projected to reach US$ 1661.8 million by 2029, at a CAGR of 6.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Long-Acting Reversible Contraception(LARC) market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Long-Acting Reversible Contraception(LARC) market.
Market Overview: The report provides a comprehensive overview of the Long-Acting Reversible Contraception(LARC) market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Intrauterine Devices (IUCs), Subcutaneous Implant), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Long-Acting Reversible Contraception(LARC) market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Long-Acting Reversible Contraception(LARC) market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Long-Acting Reversible Contraception(LARC) market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Long-Acting Reversible Contraception(LARC) market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Long-Acting Reversible Contraception(LARC) market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Long-Acting Reversible Contraception(LARC) market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Long-Acting Reversible Contraception(LARC), including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Long-Acting Reversible Contraception(LARC) market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Long-Acting Reversible Contraception(LARC) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Intrauterine Devices (IUCs)
Subcutaneous Implant
Market segment by Application
Age 20~24 Years Old
Age 25-34 Years Old
Age 35~44 Years Old
Other
Global Long-Acting Reversible Contraception(LARC) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Bayer
Merck
Teva Pharmaceutical
Allergan
HRA Pharma
Eurogine
Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
Wuxi Tianyi Medical Equipment Co., Ltd.
SMB Corporation
Shenyang Liren
Tianjin Hejie Medical Equipment Co., Ltd.
Cooper Companies
AbbVie Allergan
Organon
Shanghai Dahua Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Long-Acting Reversible Contraception(LARC), market overview.
Chapter 2: Global Long-Acting Reversible Contraception(LARC) market size in revenue and volume.
Chapter 3: Detailed analysis of Long-Acting Reversible Contraception(LARC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Long-Acting Reversible Contraception(LARC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Long-Acting Reversible Contraception(LARC) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Long-Acting Reversible Contraception(LARC) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long-Acting Reversible Contraception(LARC) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Long-Acting Reversible Contraception(LARC) Overall Market Size
2.1 Global Long-Acting Reversible Contraception(LARC) Market Size: 2022 VS 2029
2.2 Global Long-Acting Reversible Contraception(LARC) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Long-Acting Reversible Contraception(LARC) Sales: 2018-2029
3 Company Landscape
3.1 Top Long-Acting Reversible Contraception(LARC) Players in Global Market
3.2 Top Global Long-Acting Reversible Contraception(LARC) Companies Ranked by Revenue
3.3 Global Long-Acting Reversible Contraception(LARC) Revenue by Companies
3.4 Global Long-Acting Reversible Contraception(LARC) Sales by Companies
3.5 Global Long-Acting Reversible Contraception(LARC) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Long-Acting Reversible Contraception(LARC) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Long-Acting Reversible Contraception(LARC) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Long-Acting Reversible Contraception(LARC) Players in Global Market
3.8.1 List of Global Tier 1 Long-Acting Reversible Contraception(LARC) Companies
3.8.2 List of Global Tier 2 and Tier 3 Long-Acting Reversible Contraception(LARC) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Long-Acting Reversible Contraception(LARC) Market Size Markets, 2022 & 2029
4.1.2 Intrauterine Devices (IUCs)
4.1.3 Subcutaneous Implant
4.2 By Type – Global Long-Acting Reversible Contraception(LARC) Revenue & Forecasts
4.2.1 By Type – Global Long-Acting Reversible Contraception(LARC) Revenue, 2018-2023
4.2.2 By Type – Global Long-Acting Reversible Contraception(LARC) Revenue, 2024-2029
4.2.3 By Type – Global Long-Acting Reversible Contraception(LARC) Revenue Market Share, 2018-2029
4.3 By Type – Global Long-Acting Reversible Contraception(LARC) Sales & Forecasts
4.3.1 By Type – Global Long-Acting Reversible Contraception(LARC) Sales, 2018-2023
4.3.2 By Type – Global Long-Acting Reversible Contraception(LARC) Sales, 2024-2029
4.3.3 By Type – Global Long-Acting Reversible Contraception(LARC) Sales Market Share, 2018-2029
4.4 By Type – Global Long-Acting Reversible Contraception(LARC) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Long-Acting Reversible Contraception(LARC) Market Size, 2022 & 2029
5.1.2 Age 20~24 Years Old
5.1.3 Age 25-34 Years Old
5.1.4 Age 35~44 Years Old
5.1.5 Other
5.2 By Application – Global Long-Acting Reversible Contraception(LARC) Revenue & Forecasts
5.2.1 By Application – Global Long-Acting Reversible Contraception(LARC) Revenue, 2018-2023
5.2.2 By Application – Global Long-Acting Reversible Contraception(LARC) Revenue, 2024-2029
5.2.3 By Application – Global Long-Acting Reversible Contraception(LARC) Revenue Market Share, 2018-2029
5.3 By Application – Global Long-Acting Reversible Contraception(LARC) Sales & Forecasts
5.3.1 By Application – Global Long-Acting Reversible Contraception(LARC) Sales, 2018-2023
5.3.2 By Application – Global Long-Acting Reversible Contraception(LARC) Sales, 2024-2029
5.3.3 By Application – Global Long-Acting Reversible Contraception(LARC) Sales Market Share, 2018-2029
5.4 By Application – Global Long-Acting Reversible Contraception(LARC) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Long-Acting Reversible Contraception(LARC) Market Size, 2022 & 2029
6.2 By Region – Global Long-Acting Reversible Contraception(LARC) Revenue & Forecasts
6.2.1 By Region – Global Long-Acting Reversible Contraception(LARC) Revenue, 2018-2023
6.2.2 By Region – Global Long-Acting Reversible Contraception(LARC) Revenue, 2024-2029
6.2.3 By Region – Global Long-Acting Reversible Contraception(LARC) Revenue Market Share, 2018-2029
6.3 By Region – Global Long-Acting Reversible Contraception(LARC) Sales & Forecasts
6.3.1 By Region – Global Long-Acting Reversible Contraception(LARC) Sales, 2018-2023
6.3.2 By Region – Global Long-Acting Reversible Contraception(LARC) Sales, 2024-2029
6.3.3 By Region – Global Long-Acting Reversible Contraception(LARC) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Long-Acting Reversible Contraception(LARC) Revenue, 2018-2029
6.4.2 By Country – North America Long-Acting Reversible Contraception(LARC) Sales, 2018-2029
6.4.3 US Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.4.4 Canada Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.4.5 Mexico Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Long-Acting Reversible Contraception(LARC) Revenue, 2018-2029
6.5.2 By Country – Europe Long-Acting Reversible Contraception(LARC) Sales, 2018-2029
6.5.3 Germany Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5.4 France Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5.5 U.K. Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5.6 Italy Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5.7 Russia Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5.8 Nordic Countries Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.5.9 Benelux Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Long-Acting Reversible Contraception(LARC) Revenue, 2018-2029
6.6.2 By Region – Asia Long-Acting Reversible Contraception(LARC) Sales, 2018-2029
6.6.3 China Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.6.4 Japan Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.6.5 South Korea Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.6.6 Southeast Asia Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.6.7 India Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Long-Acting Reversible Contraception(LARC) Revenue, 2018-2029
6.7.2 By Country – South America Long-Acting Reversible Contraception(LARC) Sales, 2018-2029
6.7.3 Brazil Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.7.4 Argentina Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales, 2018-2029
6.8.3 Turkey Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.8.4 Israel Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.8.5 Saudi Arabia Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
6.8.6 UAE Long-Acting Reversible Contraception(LARC) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.1.4 Bayer Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.2.4 Merck Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Company Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.3.4 Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Key News & Latest Developments
7.4 Allergan
7.4.1 Allergan Company Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.4.4 Allergan Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.4.5 Allergan Key News & Latest Developments
7.5 HRA Pharma
7.5.1 HRA Pharma Company Summary
7.5.2 HRA Pharma Business Overview
7.5.3 HRA Pharma Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.5.4 HRA Pharma Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.5.5 HRA Pharma Key News & Latest Developments
7.6 Eurogine
7.6.1 Eurogine Company Summary
7.6.2 Eurogine Business Overview
7.6.3 Eurogine Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.6.4 Eurogine Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.6.5 Eurogine Key News & Latest Developments
7.7 Yantai Family Planning Pharmaceutical Equipment Co., Ltd.
7.7.1 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Company Summary
7.7.2 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Business Overview
7.7.3 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.7.4 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.7.5 Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Key News & Latest Developments
7.8 Wuxi Tianyi Medical Equipment Co., Ltd.
7.8.1 Wuxi Tianyi Medical Equipment Co., Ltd. Company Summary
7.8.2 Wuxi Tianyi Medical Equipment Co., Ltd. Business Overview
7.8.3 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.8.4 Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.8.5 Wuxi Tianyi Medical Equipment Co., Ltd. Key News & Latest Developments
7.9 SMB Corporation
7.9.1 SMB Corporation Company Summary
7.9.2 SMB Corporation Business Overview
7.9.3 SMB Corporation Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.9.4 SMB Corporation Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.9.5 SMB Corporation Key News & Latest Developments
7.10 Shenyang Liren
7.10.1 Shenyang Liren Company Summary
7.10.2 Shenyang Liren Business Overview
7.10.3 Shenyang Liren Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.10.4 Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.10.5 Shenyang Liren Key News & Latest Developments
7.11 Tianjin Hejie Medical Equipment Co., Ltd.
7.11.1 Tianjin Hejie Medical Equipment Co., Ltd. Company Summary
7.11.2 Tianjin Hejie Medical Equipment Co., Ltd. Business Overview
7.11.3 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.11.4 Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.11.5 Tianjin Hejie Medical Equipment Co., Ltd. Key News & Latest Developments
7.12 Cooper Companies
7.12.1 Cooper Companies Company Summary
7.12.2 Cooper Companies Business Overview
7.12.3 Cooper Companies Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.12.4 Cooper Companies Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.12.5 Cooper Companies Key News & Latest Developments
7.13 AbbVie Allergan
7.13.1 AbbVie Allergan Company Summary
7.13.2 AbbVie Allergan Business Overview
7.13.3 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.13.4 AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.13.5 AbbVie Allergan Key News & Latest Developments
7.14 Organon
7.14.1 Organon Company Summary
7.14.2 Organon Business Overview
7.14.3 Organon Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.14.4 Organon Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.14.5 Organon Key News & Latest Developments
7.15 Shanghai Dahua Pharmaceutical
7.15.1 Shanghai Dahua Pharmaceutical Company Summary
7.15.2 Shanghai Dahua Pharmaceutical Business Overview
7.15.3 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Major Product Offerings
7.15.4 Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales and Revenue in Global (2018-2023)
7.15.5 Shanghai Dahua Pharmaceutical Key News & Latest Developments
8 Global Long-Acting Reversible Contraception(LARC) Production Capacity, Analysis
8.1 Global Long-Acting Reversible Contraception(LARC) Production Capacity, 2018-2029
8.2 Long-Acting Reversible Contraception(LARC) Production Capacity of Key Manufacturers in Global Market
8.3 Global Long-Acting Reversible Contraception(LARC) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Long-Acting Reversible Contraception(LARC) Supply Chain Analysis
10.1 Long-Acting Reversible Contraception(LARC) Industry Value Chain
10.2 Long-Acting Reversible Contraception(LARC) Upstream Market
10.3 Long-Acting Reversible Contraception(LARC) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Long-Acting Reversible Contraception(LARC) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
